Ligand Pharmaceuticals, Inc. (LGND)
274.88
+11.74
(+4.46%)
USD |
NASDAQ |
Jun 18, 16:00
274.92
+0.04
(+0.01%)
After-Hours: 20:00
Ligand Pharmaceuticals Accounts Payable (Quarterly) : 5.264M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.264M |
| December 31, 2025 | 3.238M |
| September 30, 2025 | 3.679M |
| June 30, 2025 | 8.584M |
| March 31, 2025 | 5.366M |
| December 31, 2024 | 5.233M |
| September 30, 2024 | 4.694M |
| June 30, 2024 | 1.793M |
| March 31, 2024 | 1.893M |
| December 31, 2023 | 2.427M |
| September 30, 2023 | 2.475M |
| June 30, 2023 | 9.582M |
| March 31, 2023 | 6.135M |
| December 31, 2022 | 5.307M |
| September 30, 2022 | 15.89M |
| June 30, 2022 | 19.15M |
| March 31, 2022 | 6.972M |
| December 31, 2021 | 8.403M |
| September 30, 2021 | 7.233M |
| June 30, 2021 | 17.27M |
| March 31, 2021 | 9.469M |
| December 31, 2020 | 3.784M |
| September 30, 2020 | 10.17M |
| June 30, 2020 | 6.103M |
| March 31, 2020 | 3.365M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.42M |
| September 30, 2019 | 2.04M |
| June 30, 2019 | 2.888M |
| March 31, 2019 | 5.061M |
| December 31, 2018 | 4.183M |
| September 30, 2018 | 1.647M |
| June 30, 2018 | 2.682M |
| March 31, 2018 | 3.407M |
| December 31, 2017 | 2.259M |
| September 30, 2017 | 3.617M |
| June 30, 2017 | 1.799M |
| March 31, 2017 | 6.456M |
| December 31, 2016 | 2.734M |
| September 30, 2016 | 2.757M |
| June 30, 2016 | 2.336M |
| March 31, 2016 | 2.688M |
| December 31, 2015 | 4.083M |
| September 30, 2015 | 3.143M |
| June 30, 2015 | 2.708M |
| March 31, 2015 | 7.442M |
| December 31, 2014 | 7.698M |
| September 30, 2014 | 4.864M |
| June 30, 2014 | 5.059M |
| March 31, 2014 | 3.675M |
| December 31, 2013 | 3.951M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Organon & Co. | 983.00M |
| Johnson & Johnson | 10.46B |
| Eli Lilly & Co. | 5.029B |
| Merck & Co., Inc. | 3.863B |
| ANI Pharmaceuticals, Inc. | 69.69M |